GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JFL Life Sciences Ltd (NSE:JFLLIFE) » Definitions » Pretax Margin %

JFL Life Sciences (NSE:JFLLIFE) Pretax Margin % : 8.16% (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is JFL Life Sciences Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. JFL Life Sciences's Pre-Tax Income for the six months ended in Mar. 2024 was ₹38.0 Mil. JFL Life Sciences's Revenue for the six months ended in Mar. 2024 was ₹465.5 Mil. Therefore, JFL Life Sciences's pretax margin for the quarter that ended in Mar. 2024 was 8.16%.

The historical rank and industry rank for JFL Life Sciences's Pretax Margin % or its related term are showing as below:

NSE:JFLLIFE' s Pretax Margin % Range Over the Past 10 Years
Min: 1.33   Med: 5.22   Max: 11.31
Current: 8.16


NSE:JFLLIFE's Pretax Margin % is ranked better than
56.28% of 972 companies
in the Drug Manufacturers industry
Industry Median: 6.085 vs NSE:JFLLIFE: 8.16

JFL Life Sciences Pretax Margin % Historical Data

The historical data trend for JFL Life Sciences's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JFL Life Sciences Pretax Margin % Chart

JFL Life Sciences Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Pretax Margin %
Get a 7-Day Free Trial 1.65 2.28 11.31 8.68 8.16

JFL Life Sciences Semi-Annual Data
Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Pretax Margin % Get a 7-Day Free Trial 1.65 2.28 11.31 8.68 8.16

Competitive Comparison of JFL Life Sciences's Pretax Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, JFL Life Sciences's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JFL Life Sciences's Pretax Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, JFL Life Sciences's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where JFL Life Sciences's Pretax Margin % falls into.


;
;

JFL Life Sciences Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

JFL Life Sciences's Pretax Margin for the fiscal year that ended in Mar. 2024 is calculated as

Pretax Margin=Pre-Tax Income (A: Mar. 2024 )/Revenue (A: Mar. 2024 )
=37.999/465.479
=8.16 %

JFL Life Sciences's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=37.999/465.479
=8.16 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


JFL Life Sciences  (NSE:JFLLIFE) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


JFL Life Sciences Pretax Margin % Related Terms

Thank you for viewing the detailed overview of JFL Life Sciences's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


JFL Life Sciences Business Description

Traded in Other Exchanges
N/A
Address
Jodhpur Cross Road, 309, Satyam Mall, Opposite Saman Complex, Near Vishweshwar Mahadev Mandir, Settelite, Ahmedabad, GJ, IND, 380015
JFL Life Sciences Ltd is engaged in the business of manufacturing pharmaceutical products. The company's product portfolio consists of Dry powder injections (B-Lactam), Tablets and Capsules (B-Lactam) solid oral dosage forms, and general tablets and capsules. Its operating segment comprises of manufacturing and selling of pharmaceutical products. Geographically, the company sells its products both in India and outside India.

JFL Life Sciences Headlines

No Headlines